• PDA TR 59

PDA TR 59

  • Technical Report No. 59 (TR 59) Utilization of Statistical Methods for Production Monitoring
  • Report / Survey by Parenteral Drug Association, 11/01/2012
  • Category: PDA

$325.00 $163.00

The purpose of Technical Report No. 59, Utilization of Statistical Methods for Production Monitoring is to present relevant and easy to use Statistical Process Control Methods that are applicable to our industry. The Technical Report is the latest produced as part of PDA's Paradigm Change in Manufacturing OperationsSM initiative. PDA's Latest Technical Report Demystifies Statistical Methods The pharmaceutical industry has seen increasing recognition in the role of statistical methods. As manufacturers seek to consistently produce products that conform to predetermined quality characteristics, statistical methods have historically shown their value in providing objective evidence in meeting this goal. Statistics are also fundamental for the process understanding that is requisite for process improvement and development. Industry and regulatory bodies like the International Committee for Harmonization, the International Standards Organization and the European Union have provided guidance on the use of statistical methods. To help facilitate this process, PDA's Utilization of Statistical Methods for Production and Business Processes Task Force has produced a technical report that provides guidance in identifying and using statistical methods. The primary objective of this task force was to convey the appropriate use of statistical methods at a level most can understand.
PDF

All of our standards document are available in PDF (Portable Document Format), an electronic, downloadable format.You will be able to download the file in your account downloads.

Multi-User Access

After purchasing, you have the ability to assign each license to a specific user.

Printable

At any time, you are permitted to make printed copies for your and your members' reference use.

PDA TR 67

PDA TR 67

Technical Report No. 67, (TR 67) Exclusion of Objectionable Microorganisms from Nonsterile Pharmaceu..

$163.00 $325.00

PDA TR 68

PDA TR 68

Technical Report No. 68, (TR 68) Risk-Based Approach for Prevention and Management of Drug Shortages..

$86.00 $171.00

PDA TR 54-4

PDA TR 54-4

Technical Report No. 54-4, (TR 54-4) Implementation of Quality Risk Management for Pharmaceutical an..

$163.00 $325.00

PDA TR 57-2

PDA TR 57-2

Technical Report No. 57-2, (TR 57-2) Analytical Method Development and Qualification for Biotechnolo..

$163.00 $325.00